These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2428694)

  • 1. [Effects of a chlormadinone acetate-containing ovulation inhibitor on androgenization pictures and liver and lipid metabolism in young females].
    Cirkel U; Belkien L; Hanker JP; Schweppe KW; Schneider HP
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):439-43. PubMed ID: 2428694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a new hormonal contraceptive (Neo-Eunomin) in females with androgenization symptoms].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):651-5. PubMed ID: 6083897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G; Cunliffe WJ; Binder N; Höschen K
    Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-androgens. Their use in dermatology].
    Montero ED; Arevalo A; Michelotti M
    Med Cutan Ibero Lat Am; 1981; 9(4):275-84. PubMed ID: 6456390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of oral contraceptives on male-pattern alopecia, seborrhoea, acne vulgaris and hirsutism. Anamnestic study on 325 women].
    Hoffmann E; Meiers HG; Hubbes A
    Dtsch Med Wochenschr; 1974 Oct; 99(43):2151-4, 2157. PubMed ID: 4139008
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term studies with an anti-androgen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females].
    Kaiser E; Gruner S
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):298-303. PubMed ID: 1830560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of virilization with an antiandrogen-containing contraceptive].
    Apró G; Sas M
    Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.
    Guido M; Romualdi D; Campagna G; Ricciardi L; Bompiani A; Lanzone A
    Reprod Sci; 2010 Aug; 17(8):767-75. PubMed ID: 20595709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of anti-androgens in skin diseases].
    Nolting S
    Z Hautkr; 1979 Jun; 54(12):529-32. PubMed ID: 88827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate].
    Grund E; Schmidt-Elmendorff H
    Med Welt; 1975 Nov; 26(48):2180-7. PubMed ID: 128684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
    Marianowski L; Cyganek A; Grzechocińska B
    Wiad Lek; 1994 Oct; 47(19-20):745-6. PubMed ID: 7483620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of moderately severe virilism of women with Diane and Androcur 10].
    Döring HF; Ilgner M
    Z Hautkr; 1983 May; 58(10):761-7. PubMed ID: 6224353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyproterone acetate - ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia.
    Nardi M; De Aloysio D; Busacchi P; Flamigni C
    Acta Eur Fertil; 1975 Jun; 6(2):153-65. PubMed ID: 127497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with the anti-androgens in the female].
    Kaiser E; Loch EG; Winckelmann G; Schröpl F; Dietz M; Hartmann P
    Med Welt; 1976 Sep; 27(39):1836-41. PubMed ID: 135909
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications and limits of anti-androgen therapy].
    Zaun H
    Z Hautkr; 1984 Aug; 59(16):1090-7. PubMed ID: 6207673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV; Korchevaia TA; Kravchenko LIa
    Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.